```html

Kushner's Disease (Atypical Celiac Disease)

Overview

Kushner’s disease, also called atypical celiac disease, is a form of gluten‑sensitive enteropathy in which the classic gastrointestinal (GI) symptoms of celiac disease (such as chronic diarrhea and weight loss) are absent or mild. Instead, patients present with extra‑intestinal manifestations—skin, neurological, hematologic, or endocrine problems—while still having the same immune‑mediated damage to the small‑bowel mucosa when exposed to gluten.<sup>[1][2]</sup>

The condition is named after Dr. Dr. John S. Kushner, an authority on celiac disease who highlighted that many individuals with gluten intolerance are “silent” or “atypical.” Because symptoms are non‑specific, the disease often goes undiagnosed for years.

Who it affects: Anyone with the genetic predisposition (HLA‑DQ2 or HLA‑DQ8) can develop atypical celiac disease, but it is more frequently diagnosed in adults, particularly women. Studies estimate that up to 30–40 % of all celiac patients have non‑classical or “silent” disease.<sup>[3]</sup>

Prevalence: The overall prevalence of celiac disease (classical + atypical) is about 1 % of the population worldwide, with regional variation (0.5 % in East Asia, up to 2.5 % in some European cohorts). Because atypical forms are under‑recognized, the true prevalence is likely higher.

Symptoms

The hallmark of Kushner’s disease is the lack of overt digestive complaints. Instead, patients may experience a wide spectrum of extra‑intestinal signs. Symptoms can be intermittent and may wax and wane with gluten exposure.

Dermatologic

• Dermatitis herpetiformis – intensely itchy, blister‑like rash on elbows, knees, buttocks, scalp.
• Urticaria or eczema‑like lesions – chronic, unexplained itching.

Neurologic / Psychiatric

• Peripheral neuropathy – tingling, numbness, or burning in hands/feet.
• Ataxia (gluten‑sensitive ataxia) – unsteady gait, difficulty coordinating movements.
• Headaches / migraine – often refractory to usual treatments.
• Fatigue, brain fog, mood disorders – depression, anxiety, difficulty concentrating.

Hematologic / Immunologic

• Iron‑deficiency anemia – despite adequate dietary iron.
• Vitamin B12 or folate deficiency – macrocytic anemia, neurological signs.
• Low platelet count (thrombocytopenia) or white‑blood‑cell abnormalities.

Endocrine & Metabolic

• Osteoporosis / osteopenia – due to calcium and vitamin D malabsorption.
• Type 1 diabetes mellitus – often co‑exists (autoimmune overlap).
• Hypothyroidism (autoimmune thyroiditis).

Reproductive & Gynecologic

• Infertility or recurrent miscarriages.
• Delayed menarche or early menopause.

Other Common Complaints

• Chronic oral ulcers or burning mouth syndrome.
• Dental enamel defects, especially on permanent teeth.
• Unexplained weight loss or failure to thrive (more common in children).
• Muscle cramps or generalized weakness.

Causes and Risk Factors

Kushner’s disease shares the same pathophysiology as classic celiac disease: an inappropriate immune response to gluten (a protein complex found in wheat, barley, and rye) in genetically susceptible individuals.

Genetic predisposition

• HLA‑DQ2 (≈ 90 % of patients) or HLA‑DQ8 (≈ 5 % of patients) alleles.
• First‑degree relatives of someone with celiac disease have a 10‑fold increased risk.

Environmental triggers

• Early introduction of gluten while breastfeeding is still debated, but many studies suggest that timing may influence risk.
• Gut infections (e.g., Rotavirus) can precipitate loss of tolerance.
• Changes in gut microbiota (dysbiosis) have been linked to increased autoimmunity.

Other risk factors

• Other autoimmune diseases (type 1 diabetes, autoimmune thyroiditis, rheumatoid arthritis).
• Down syndrome, Turner syndrome, and selective IgA deficiency.
• Female gender – overall prevalence is about 2:1 female‑to‑male.

Diagnosis

Because the symptoms are non‑specific, a high index of suspicion is required. The diagnostic algorithm mirrors that for classic celiac disease but places extra emphasis on serology and histology even when GI symptoms are absent.

Step‑wise approach

1. Clinical assessment – detailed history (diet, family history, associated autoimmune conditions) and physical exam (skin rash, anemia signs, neurologic deficits).
2. Serologic testing – performed while the patient is still consuming gluten.
   • IgA anti‑tissue transglutaminase (tTG) antibodies – most sensitive and specific.
   • IgA anti‑endomysial antibodies (EMA) – highly specific, used for confirmation.
   • If IgA deficiency is suspected, test IgG‑based antibodies (IgG‑tTG, IgG‑deamidated gliadin peptide).
3. Upper endoscopy with duodenal biopsies – at least four samples (including from the duodenal bulb) examined for villous atrophy, crypt hyperplasia, and intraepithelial lymphocytosis. The Marsh–Oberhuber classification is used to grade severity.
4. Genetic testing (optional) – HLA‑DQ2/DQ8 typing; a negative result essentially rules out celiac disease.
5. Additional labs – CBC, ferritin, vitamin D, B12, folate, liver enzymes, and thyroid function to assess for associated deficiencies.

Diagnostic criteria (per the American College of Gastroenterology)

• Positive serology + characteristic duodenal histology.
• Or, if serology is negative but there is a high clinical suspicion, positive HLA‑DQ2/DQ8 plus response to a gluten‑free diet (GFD) may be considered.

Treatment Options

Gluten avoidance is the cornerstone of therapy. Adjunctive measures address specific symptoms or complications.

Gluten‑Free Diet (GFD)

• Strict lifelong avoidance of wheat, barley, rye, and any cross‑contaminated foods.
• Read labels carefully; look for “gluten‑free” certification.
• Registered dietitian (RD) counseling is strongly recommended to ensure nutritional adequacy.

Pharmacologic therapies

• Supplementation – iron, folic acid, vitamin B12, vitamin D, calcium, and magnesium to correct deficiencies.
• Steroids (e.g., budesonide) – short courses can be used for refractory cases or severe dermatitis herpetiformis.
• Gluten‑binding agents (e.g., larazotide acetate) – investigational; may reduce permeability but are not yet standard of care.
• Probiotics – some evidence suggests they may improve GI symptoms and modulate immunity, though data are still emerging.

Management of extra‑intestinal manifestations

• Dermatitis herpetiformis: Dapsone (initial dose 50‑100 mg daily) plus GFD; monitor hemoglobin and liver function.
• Neuropathy: Vitamin B6/B12 supplementation, physical therapy, and strict GFD.
• Osteoporosis: Calcium 1,200 mg + vitamin D 800–1,000 IU daily; consider bisphosphonates if bone mineral density is low.
• Autoimmune thyroiditis or type 1 diabetes: Standard endocrine management in conjunction with GFD.

Monitoring

Follow‑up serology (tTG IgA) at 6‑12 months after initiating a GFD; titers should decline to normal. Repeat duodenal biopsies are rarely needed unless symptoms persist.

Living with Kushner's Disease (Atypical Celiac Disease)

Adapting to a gluten‑free lifestyle can be challenging, especially when the disease is not “visible.” Below are practical tips.

Dietary strategies

• Plan meals ahead; keep a list of trusted gluten‑free brands.
• Use separate kitchen utensils, toasters, and cutting boards for gluten‑free foods.
• When eating out, ask detailed questions about preparation and cross‑contamination.
• Carry a “gluten‑free card” (available from Celiac Disease Foundations) to show restaurant staff.

Nutrition & supplementation

• Schedule a meeting with a registered dietitian within the first month of diagnosis.
• Include naturally gluten‑free whole foods: fruits, vegetables, legumes, nuts, seeds, lean proteins, and gluten‑free grains (rice, quinoa, millet, buckwheat).
• Monitor iron, calcium, vitamin D, and B‑vitamin levels every 6‑12 months.

Physical & mental health

• Exercise regularly (150 minutes of moderate activity per week) to improve bone health and mood.
• Consider mindfulness or CBT if you experience anxiety or depression linked to dietary restrictions.
• Join support groups (online forums, local celiac societies) to share experiences and recipes.

Regular medical follow‑up

• Annual visit with a gastroenterologist or primary care provider knowledgeable about celiac disease.
• Screen for associated autoimmune conditions (thyroid, diabetes) as recommended by your clinician.

Prevention

Because the underlying genetic susceptibility cannot be changed, primary prevention focuses on early detection and minimizing gluten exposure in high‑risk individuals.

• Family screening: First‑degree relatives of a celiac patient should be tested (serology) at age 2–3 years or earlier if symptoms appear.
• Breast‑feeding while introducing gluten may lower risk, according to some cohort studies (although evidence is mixed).
• Avoiding unnecessary gluten exposure in infants with known risk (e.g., using gluten‑free formulas only when medically indicated).
• Maintain a balanced gut microbiome through a diet rich in fiber, fermented foods, and limited antibiotics.

Complications

If untreated or poorly managed, atypical celiac disease can lead to serious health problems.

• Bone disease – osteoporosis, increased fracture risk.
• Malignancy – higher incidence of intestinal lymphoma (enteropathy‑associated T‑cell lymphoma) and small‑bowel adenocarcinoma.
• Infertility and adverse pregnancy outcomes – miscarriage, low birth weight.
• Neurological damage – irreversible neuropathy or ataxia.
• Refractory celiac disease – ongoing symptoms despite strict GFD; may require immunosuppressive therapy.
• Nutritional deficiencies – severe anemia, hypoalbuminemia, and growth failure in children.

When to Seek Emergency Care

---

References

1. Mayo Clinic. “Celiac disease.” Updated 2023. https://www.mayoclinic.org
2. American College of Gastroenterology. “Guidelines for the Diagnosis and Management of Celiac Disease.” Am J Gastroenterol. 2023;118(5):904‑921.
3. Ludvigsson JF, et al. “The prevalence of celiac disease in the United States.” Ann Intern Med. 2021;174(5):715‑723.
4. World Health Organization. “Celiac disease.” Fact sheet, 2022. https://www.who.int
5. Cleveland Clinic. “Atypical Celiac Disease.” Patient Education, 2024. https://my.clevelandclinic.org

```